Summary: The Neurology Minute podcast delivers a brief daily summary of what you need to know in the field of neurology, the latest science focused on the brain, and timely topics explored by leading neurologists and neuroscientists. From the American Academy of Neurology and hosted by Dr. Stacey Clardy with contributions by experts from the Neurology journals, Neurology Today, Continuum, and more.
Dr. Eoin Flanagan discusses progressive solitary sclerosis.
Dr. Jeff Ratliff highlights a Neurology Today article in discussing cancer risk in Parkinson disease. Read the article here: https://journals.lww.com/neurotodayonline/Fulltext/2019/09190/In_Small_Study,_Parkinson_s_Disease_Patients_with.1.aspx.
Dr. Christopher Glisson discusses diplopia in the second part of a three-part series. To learn more, read the article "Approach to Diplopia" by Dr. Glisson in the October 2019 Neuro-ophthalmology issue of Continuum.
Dr. Randall Bateman gives the main takeaways from his paper addressing how high precision plasma amyloid-β 42/40 predicts current and future brain amyloidosis.
In this highlight from our longer interview with Dr. Stanley Prusiner, Dr. Prusiner talks about what he would do differently if he could go back and do it all over.
In the sixth part of an extended series with interviewer Dr. David Lapides, Dr. Jon Stone discusses how to discuss FND diagnosis with patients in clinic.
Dr. Aaron Rothstein discusses cerebral amyloid angiopathy.
Dr. Christopher Glisson discusses diplopia in the first part of a three-part series. To learn more, read the article "Approach to Diplopia" by Dr. Glisson in the October 2019 Neuro-ophthalmology issue of Continuum.
Dr. Ylva Hiorth provides the main clinical messages from her study on orthostatic hypertension in Parkinson disease.
Listen to an excerpt from the interview with Nobel Prize winner Dr. Stanley Prusiner.
In the fifth part of an extended series with interviewer Dr. David Lapides, Dr. Jon Stone discusses differentiating FNDs and malingering symptoms in patients.
Dr. Aaron Rothstein discusses a paper in the Resident & Fellow section on hippocampal sclerosis in cerebral malaria.
Dr. Eoin Flanagan discusses anti-Ma2 paraneoplastic syndrome.
Dr. Kiran Thakur and Dr. Greer Waldrop give the main takeaways from their paper on the World Health Organization’s essential diagnostics list.
Dr. Sean Pittock discusses the main takeaways from his article on eculizumab in aquaporin-4–positive neuromyelitis optica spectrum disorder.